BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
279.99
+4.65 (1.69%)
At close: Jun 26, 2026, 4:00 PM EDT
279.89
-0.10 (-0.04%)
After-hours: Jun 26, 2026, 4:10 PM EDT
BeOne Medicines AG Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for BeOne Medicines AG stock have an average target of 398.45, with a low estimate of 333 and a high estimate of 453. The average target predicts an increase of 42.31% from the current stock price of 279.99.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BeOne Medicines AG stock from 28 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 18 | 18 | 18 | 18 | 19 | 19 |
| Buy | 7 | 7 | 7 | 7 | 8 | 8 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 26 | 26 | 26 | 26 | 28 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Maintains $420 | Buy | Maintains | $420 | +50.01% | Jun 15, 2026 |
| Barclays | Barclays | Buy Maintains $409 | Buy | Maintains | $409 | +46.08% | Jun 15, 2026 |
| Citi | Citi | Buy Maintains $453 | Buy | Maintains | $453 | +61.79% | Jun 12, 2026 |
| Wolfe Research | Wolfe Research | Buy Maintains $340 | Buy | Maintains | $340 | +21.43% | Jun 3, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 2, 2026 |
Financial Forecast
Revenue This Year
45.32B
from 37.37B
Increased by 21.27%
Revenue Next Year
52.00B
from 45.32B
Increased by 14.74%
EPS This Year
3.51
from 1.33
Increased by 164.37%
EPS Next Year
5.37
from 3.51
Increased by 52.77%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 47.9B | 57.9B | |
| Avg | 45.3B | 52.0B | |
| Low | 43.4B | 47.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.1% | 27.9% | |
| Avg | 21.3% | 14.7% | |
| Low | 16.3% | 5.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.10 | 7.09 | |
| Avg | 3.51 | 5.37 | |
| Low | 2.94 | 3.99 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 283.7% | 101.8% | |
| Avg | 164.4% | 52.8% | |
| Low | 121.1% | 13.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.